This site is intended for healthcare professionals only
LoginRegister
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun PharmaCourt Removes Injunction on Sun Pharma's LEQSELVI Launch in US
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark gets CDSCO Panel nod to study Glycopyrronium, Fluticasone Furoate, Vilanterol Powder for...
Sanofi India Rodolfo Hrosz resigns as MDSanofi India Rodolfo Hrosz resigns as MD
Granules recalls over 33000 bottles BP medication in USBiocon, Glenmark recall anxiety, high cholesterol medications in US
CDSCO Launches One-Year Online Dual Use NOC System for Bulk Drug ImportsNo Free Pass: CDSCO Mandates Registration, Import License for SEZ Drugs Sold in India
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanShilpa Medicare bags USFDA approval for Varenicline Tablets for smoking cessation
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance OfficerBiocon Biologics gets USFDA nod for cancer drug Jobevne
Aurobindo Pharma restarts production at Kakinada Penicillin-G plant after fire incidentAurobindo Pharma arm CuraTeQ Biologics completes successful Phase 1 Pharmacokinetics study of bone...
Shaik Barak Tulla joins Sun Pharma as Senior Vice President and Head of Acute ClustersShaik Barak Tulla joins Sun Pharma as Senior Vice President and Head of Acute Clusters
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Healthcare Gets CDSCO Panel Nod To study Vilanterol plus Umeclidinium powder for inhalation
Indian Pharma Market Grows 8.7% in August, Records Rs 20,984 Crore Sales: PharmaTracCardiac, GI Power Indian Pharma Market's 7.5% March Surge
Fake WHO, Abbott Emails Used in Over Rs 1.1 Crore Scam on Pharma Executive, 2 NabbedAhmedabad-Based Troikaa Pharma Falls Victim To Rs 50 Lakh Cyber Fraud
X